Hyo Song Kim

5.2k total citations
182 papers, 3.7k citations indexed

About

Hyo Song Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hyo Song Kim has authored 182 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Pulmonary and Respiratory Medicine, 94 papers in Oncology and 49 papers in Surgery. Recurrent topics in Hyo Song Kim's work include Gastric Cancer Management and Outcomes (61 papers), Sarcoma Diagnosis and Treatment (38 papers) and Colorectal Cancer Treatments and Studies (22 papers). Hyo Song Kim is often cited by papers focused on Gastric Cancer Management and Outcomes (61 papers), Sarcoma Diagnosis and Treatment (38 papers) and Colorectal Cancer Treatments and Studies (22 papers). Hyo Song Kim collaborates with scholars based in South Korea, United States and China. Hyo Song Kim's co-authors include Sun Young Rha, Hyun Cheol Chung, Minkyu Jung, Sung Hoon Noh, Woo Jin Hyung, Seong Yoon Yi, Jeeyun Lee, Hei‐Cheul Jeung, Joong Bae Ahn and Jae‐Ho Cheong and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hyo Song Kim

177 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hyo Song Kim South Korea	34	2.0k	1.8k	875	809	536	182	3.7k
Tomohiro Nishina Japan	35	2.2k 1.1×	2.7k 1.5×	665 0.8×	1.1k 1.3×	450 0.8×	231	4.3k
Gennaro Galizia Italy	43	1.9k 0.9×	2.8k 1.5×	1.2k 1.3×	1.3k 1.6×	910 1.7×	140	5.2k
Roberto Petrioli Italy	28	1.2k 0.6×	1.6k 0.9×	508 0.6×	855 1.1×	407 0.8×	135	3.1k
Eva Lieto Italy	31	1.1k 0.6×	1.7k 0.9×	625 0.7×	868 1.1×	443 0.8×	67	3.1k
Michael Hejna Austria	32	1.7k 0.8×	1.9k 1.1×	768 0.9×	1.1k 1.4×	310 0.6×	107	3.8k
Itasu Ninomiya Japan	37	1.5k 0.8×	1.6k 0.9×	1.4k 1.6×	1.5k 1.8×	586 1.1×	227	4.4k
Daisuke Kobayashi Japan	35	1.8k 0.9×	1.3k 0.7×	1.1k 1.2×	1.4k 1.7×	491 0.9×	174	3.7k
Christina L. Roland United States	30	1.4k 0.7×	1.7k 0.9×	945 1.1×	612 0.8×	585 1.1×	126	3.6k
Hirotoshi Hasegawa Japan	38	1.3k 0.6×	2.9k 1.6×	538 0.6×	2.1k 2.5×	451 0.8×	175	4.6k
Sheela Rao United Kingdom	26	2.6k 1.3×	2.2k 1.2×	616 0.7×	1.6k 2.0×	293 0.5×	90	4.3k

Countries citing papers authored by Hyo Song Kim

Since Specialization

Citations

This map shows the geographic impact of Hyo Song Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyo Song Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyo Song Kim more than expected).

Fields of papers citing papers by Hyo Song Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyo Song Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyo Song Kim. The network helps show where Hyo Song Kim may publish in the future.

Co-authorship network of co-authors of Hyo Song Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hyo Song Kim. A scholar is included among the top collaborators of Hyo Song Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyo Song Kim. Hyo Song Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cho, Gyu Seok, Hyo Song Kim, Minkyu Jung, & Woo Jin Hyung. (2024). Perioperative intraperitoneal plus systemic chemotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gastric cancer: phase Ib/II single-arm prospective study. Journal of Gastrointestinal Surgery. 28(7). 1095–1103. 2 indexed citations

Koo, Dong‐Hoe, Minkyu Jung, Yeul Hong Kim, et al.. (2024). Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13). Cancer Research and Treatment. 56(4). 1136–1145. 3 indexed citations

Kim, Chang Gon, Minkyu Jung, Hyo Song Kim, et al.. (2023). Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer. Journal of Clinical Oncology. 41(27). 4394–4405. 27 indexed citations

Kwon, Jung Hye, Seung‐Hoon Beom, Sang Joon Shin, et al.. (2023). Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea. SHILAP Revista de lepidopterología. 4(1). 9–16. 1 indexed citations

Lee, Choong‐kun, Jii Bum Lee, Se Jin Park, et al.. (2023). Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study. Gastric Cancer. 27(1). 118–130. 10 indexed citations

Jung, Seung‐Hyun, Choong‐kun Lee, Woo Sun Kwon, et al.. (2023). Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy. Yonsei Medical Journal. 64(9). 531–531. 5 indexed citations

Cho, Iksung, Seng Chan You, Min Jae, et al.. (2022). Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin. Cancers. 14(9). 2320–2320. 10 indexed citations

Kim, Chang Gon, Nam Suk Sim, Jeong Eun Kim, et al.. (2022). Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma. Clinical Cancer Research. 28(15). 3225–3234. 6 indexed citations

Chae, Dongwoo, Chung Mo Nam, Joo Hoon Kim, et al.. (2018). A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy. The AAPS Journal. 20(4). 72–72.

10.

Sundar, Raghav, Sun Young Rha, Hiroki Yamaue, et al.. (2018). A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer. BMC Cancer. 18(1). 332–332. 33 indexed citations

11.

Kim, Min Hwan, Xianglan Zhang, Minkyu Jung, et al.. (2018). Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial. Cancer Research and Treatment. 51(2). 819–831. 15 indexed citations

12.

Park, Ji Soo, Seung‐Hoon Beom, Hyo Song Kim, et al.. (2017). The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status. Gastric Cancer. 21(2). 213–224. 28 indexed citations

13.

Park, Ji Soo, Sun Young Rha, Hyun Cheol Chung, et al.. (2014). Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer. Oncology. 88(3). 147–156. 14 indexed citations

14.

Zhang, Xianglan, Ji Soo Park, Minkyu Jung, et al.. (2014). PTEN Deficiency as a Predictive Biomarker of Resistance to HER2-Targeted Therapy in Advanced Gastric Cancer. Oncology. 88(2). 76–85. 32 indexed citations

15.

Sung, Joseph J.�Y., Siew C. Ng, Francis K.L. Chan, et al.. (2014). An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 64(1). 121–132. 302 indexed citations

16.

Kim, Hyo Song, Yong Jin Cho, Sun Young Rha, et al.. (2014). Vascular Soft-Tissue Sarcomas: A Prognostic Model from a Retrospective Single-Center Study. Oncology. 86(5-6). 329–335.

17.

Lee, Jae Seok, Sun Min Lim, Sun Young Rha, et al.. (2013). Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study. Journal of Clinical Pathology. 67(1). 33–39. 13 indexed citations

18.

Song, Jong Wook, Young Lan Kwak, Jin Woo Lee, et al.. (2012). The optimal effect site concentration of remifentanil in combination with intravenous midazolam and topical lidocaine for awake fibreoptic nasotracheal intubation in patients undergoing cervical spine surgery.. PubMed. 78(5). 521–6. 7 indexed citations

19.

Kim, Joo Hoon, Hyo Song Kim, Chung Mo Nam, et al.. (2011). External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer. Annals of Oncology. 23(2). 361–367. 42 indexed citations

20.

Ji, Sang Hoon, Do Hyoung Lim, Seong Yoon Yi, et al.. (2009). A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer. BMC Cancer. 9(1). 110–110. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact